Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

HARTVIGSEN & HEIN RYGCENTER OG IDRÆTSKLINIK ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6% 0.6%   Bankruptcy risk   1.3% 1.4% 1.4% 1.8% 1.6% 1.4% 7.4% 7.4%   Credit score (0-100)   83 79 77 71 75 76 33 33   Credit rating   A A A A A A BB BB   Credit limit (kDKK)   61.1 22.6 24.4 2.9 10.0 23.9 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   6,143 6,507 6,817 7,605 7,527 8,370 0.0 0.0   EBITDA   1,347 1,548 1,945 2,451 1,722 2,018 0.0 0.0   EBIT   1,135 1,337 1,724 2,231 1,505 1,697 0.0 0.0   Pre-tax profit (PTP)   1,126.5 1,325.0 1,708.8 2,211.2 1,486.4 1,682.8 0.0 0.0   Net earnings   876.1 1,031.7 1,329.5 1,719.8 1,155.2 1,309.6 0.0 0.0   Pre-tax profit without non-rec. items   1,126 1,325 1,709 2,211 1,486 1,683 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   88.4 56.9 131 90.3 273 1,089 0.0 0.0   Shareholders equity total   1,538 1,570 1,899 2,319 1,774 1,984 16.9 16.9   Interest-bearing liabilities   0.0 0.0 0.0 0.0 166 466 883 883   Balance sheet total (assets)   2,785 2,760 3,637 3,484 2,754 3,450 900 900   Net Debt   -240 -406 -572 -256 159 450 883 883     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   6,143 6,507 6,817 7,605 7,527 8,370 0.0 0.0   Gross profit growth   -3.7% 5.9% 4.8% 11.6% -1.0% 11.2% -100.0% 0.0%   Employees   9 9 10 11 11 12 0 0   Employee growth %   -10.0% 0.0% 11.1% 10.0% 0.0% 9.1% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,785 2,760 3,637 3,484 2,754 3,450 900 900   Balance sheet change%   -25.6% -0.9% 31.8% -4.2% -21.0% 25.3% -73.9% 0.0%   Added value   1,346.8 1,548.5 1,944.5 2,451.0 1,725.5 2,017.5 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -423 -423 -327 -441 -215 316 -1,089 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   18.5% 20.5% 25.3% 29.3% 20.0% 20.3% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   34.8% 48.2% 53.9% 62.6% 48.3% 54.7% 0.0% 0.0%   ROI %   45.2% 69.4% 83.4% 92.8% 63.0% 69.8% 0.0% 0.0%   ROE %   41.7% 66.4% 76.7% 81.5% 56.4% 69.7% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   55.2% 56.9% 52.2% 66.6% 64.4% 57.5% 1.9% 1.9%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -17.8% -26.2% -29.4% -10.4% 9.2% 22.3% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 9.4% 23.5% 5,217.6% 5,217.6%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 22.9% 4.4% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.0 1.2 1.4 2.3 1.7 1.1 0.0 0.0   Current Ratio   1.0 1.3 1.5 2.4 1.8 1.1 0.0 0.0   Cash and cash equivalent   240.2 405.7 572.0 255.9 7.2 16.8 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   41.4 245.7 643.3 1,242.5 602.5 161.9 -441.5 -441.5   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   150 172 194 223 157 168 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   150 172 194 223 157 168 0 0   EBIT / employee   126 149 172 203 137 141 0 0   Net earnings / employee   97 115 133 156 105 109 0 0